Shantell Laketa Heiber

Array ( [id] => 693903 [patent_doc_number] => 07070789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Recombinant Newcastle disease virus nucleoprotein mutant as a marker vaccine' [patent_app_type] => utility [patent_app_number] => 10/415981 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10407 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/070/07070789.pdf [firstpage_image] =>[orig_patent_app_number] => 10415981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278953 [patent_doc_number] => 06641819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-04 [patent_title] => 'Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142' [patent_app_type] => B2 [patent_app_number] => 09/981282 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25646 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/641/06641819.pdf [firstpage_image] =>[orig_patent_app_number] => 09981282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869830 [patent_doc_number] => 20030082519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Cellular kinases involved in Cytomegalovirus infection and their inhibition' [patent_app_type] => new [patent_app_number] => 09/981397 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12970 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082519.pdf [firstpage_image] =>[orig_patent_app_number] => 09981397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6079855 [patent_doc_number] => 20020081279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Chicken embryo lethal orphan (CELO) virus' [patent_app_type] => new [patent_app_number] => 09/970711 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14821 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081279.pdf [firstpage_image] =>[orig_patent_app_number] => 09970711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765269 [patent_doc_number] => 20030099667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Avian herpesvirus-based recombinant infectious bursal disease vaccine' [patent_app_type] => new [patent_app_number] => 09/964895 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6836 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20030099667.pdf [firstpage_image] =>[orig_patent_app_number] => 09964895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080463 [patent_doc_number] => 20020081627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Inhibition of adenovirus replication by product R, A peptide nucleic acid immunomodulator' [patent_app_type] => new [patent_app_number] => 09/948221 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 3430 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081627.pdf [firstpage_image] =>[orig_patent_app_number] => 09948221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1324514 [patent_doc_number] => 06599508 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-29 [patent_title] => 'Papilloma virus-like particles, fusion proteins as well as processes for their production' [patent_app_type] => B1 [patent_app_number] => 09/949404 [patent_app_country] => US [patent_app_date] => 2001-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4433 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599508.pdf [firstpage_image] =>[orig_patent_app_number] => 09949404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788279 [patent_doc_number] => 20020160932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Uncompetitive inhibitors of helicase-primase' [patent_app_type] => new [patent_app_number] => 09/943106 [patent_app_country] => US [patent_app_date] => 2001-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9400 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160932.pdf [firstpage_image] =>[orig_patent_app_number] => 09943106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545296 [patent_doc_number] => 20020137720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Papilloma virus sequences' [patent_app_type] => new [patent_app_number] => 09/939471 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13245 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137720.pdf [firstpage_image] =>[orig_patent_app_number] => 09939471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1344356 [patent_doc_number] => 06579528 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Cold-adapted equine influenza viruses' [patent_app_type] => B1 [patent_app_number] => 09/762861 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37703 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579528.pdf [firstpage_image] =>[orig_patent_app_number] => 09762861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6275765 [patent_doc_number] => 20020106639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Postweaning multisystemic wasting syndrome virus from pigs' [patent_app_type] => new [patent_app_number] => 09/935428 [patent_app_country] => US [patent_app_date] => 2001-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16817 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106639.pdf [firstpage_image] =>[orig_patent_app_number] => 09935428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1439766 [patent_doc_number] => 06495316 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Mixed cell diagnostic systems' [patent_app_type] => B1 [patent_app_number] => 09/928195 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16569 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495316.pdf [firstpage_image] =>[orig_patent_app_number] => 09928195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1024411 [patent_doc_number] => 06884605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-26 [patent_title] => 'Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer' [patent_app_type] => utility [patent_app_number] => 09/927585 [patent_app_country] => US [patent_app_date] => 2001-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 39 [patent_no_of_words] => 11710 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884605.pdf [firstpage_image] =>[orig_patent_app_number] => 09927585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1357622 [patent_doc_number] => 06573080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-03 [patent_title] => 'Mixed cell diagnostic systems' [patent_app_type] => B2 [patent_app_number] => 09/927481 [patent_app_country] => US [patent_app_date] => 2001-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16571 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573080.pdf [firstpage_image] =>[orig_patent_app_number] => 09927481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 922956 [patent_doc_number] => 07318928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Molecular vaccine linking intercellular spreading protein to an antigen' [patent_app_type] => utility [patent_app_number] => 10/343719 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 30687 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/318/07318928.pdf [firstpage_image] =>[orig_patent_app_number] => 10343719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796426 [patent_doc_number] => 20030175300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'EBV CTL epitopes' [patent_app_type] => new [patent_app_number] => 09/920195 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9819 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175300.pdf [firstpage_image] =>[orig_patent_app_number] => 09920195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6462550 [patent_doc_number] => 20020150590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'EBV CTL epitopes' [patent_app_type] => new [patent_app_number] => 09/920174 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9839 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20020150590.pdf [firstpage_image] =>[orig_patent_app_number] => 09920174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 968273 [patent_doc_number] => 06939547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-06 [patent_title] => 'Specific binding agents for KSHV vIL-6 that neutralize a biological activity' [patent_app_type] => utility [patent_app_number] => 10/333121 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24992 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/939/06939547.pdf [firstpage_image] =>[orig_patent_app_number] => 10333121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1178298 [patent_doc_number] => 06740325 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-25 [patent_title] => 'Peptide-based vaccine for influenza' [patent_app_type] => B1 [patent_app_number] => 09/856920 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 7579 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740325.pdf [firstpage_image] =>[orig_patent_app_number] => 09856920 [rel_patent_id] =>[rel_patent_doc_number] =>)